ONCOLife Articles
Radioligand Therapy Pluvicto Reduces Progression Risk by 28% in mHS Prostate Cancer
ONCOLife | 5 November 2025
Lenvatinib Plus Everolimus Improves Outcomes After PD-1 Failure in Kidney Cancer
ONCOLife | 6 November 2025
Ribociclib Extends Disease-Free Survival Beyond Treatment in HR+/HER2– Early Breast Cancer
ONCOLife | 3 November 2025
DeLLphi-303: Tarlatamab Plus Chemo Achieves 71% Response in ES Small-Cell Lung Cancer
ONCOLife | 4 November 2025
ctDNA Blood Test Guides Chemotherapy Decisions for Tailored Colon Cancer Treatment
ONCOLife | 4 November 2025
Trodelvy Emerges as Potential New Standard for First-Line Metastatic TN Breast Cancer
ONCOLife | 24 October 2025
ESMO’s Road Map for Safe and Effective Use of AI-LLMs in Cancer Care: 23 Rules from 20 Experts
AI | 3 November 2025
Datroway Extends Survival by 5 Months in Metastatic Triple-Negative Breast Cancer
ONCOLife | 21 October 2025
Molecular Trojan Horse: Peptide Nanotubes Offer a Path to Defeat Drug-Resistant Tumors
ONCOLife
13 October 2025
Reprogramming Cancer Cell Death: A New Immune-Based Strategy for Blood Cancers
ONCOLife
12 October 2025
Datroway Improves Survival in First-Line Treatment of Metastatic Triple- Breast Cancer
ONCOLife
6 October 2025
Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers
ONCOLife
1 October 2025
The VAPOR 2 Trial and the Potential of Water Vapor Ablation in Prostate Cancer Treatment
ONCOLife
2 October 2025
Giredestrant Plus Everolimus Improves PF Survival in ER+ Advanced Breast Cancer
ONCOLife
26 September 2025
The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research
ONCOLife
12 September 2025
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Clinical Trials
20 September 2025
Sugary Drinks Drive Colorectal Cancer Metastasis via SORD Pathway, Study Finds
ONCOLife
20 September 2025
FDA Grants Breakthrough Status to Raludotatug Deruxtecan for Refractory Ovarian Cancer
ONCOLife
17 September 2025
The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance
ONCOLife
17 September 2025
SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma
ONCOLife
15 September 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
